Light chain amyloidosis - current findings and future prospects.
about
Amyloid formation in light chain amyloidosisA Single Mutation Promotes Amyloidogenicity through a Highly Promiscuous Dimer InterfaceSolid-state NMR chemical shift assignments for AL-09 VL immunoglobulin light chain fibrils.Amyloidosis and POEMS syndrome.Formation of amyloid fibers by monomeric light chain variable domains.Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.IgG Fab fragments forming bivalent complexes by a conformational mechanism that is reversible by osmolytes.Proteostasis strategies for restoring alpha1-antitrypsin deficiency.Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING.Effect of amino acid mutations on the conformational dynamics of amyloidogenic immunoglobulin light-chains: A combined NMR and in silico study.Partially folded aggregation intermediates of human gammaD-, gammaC-, and gammaS-crystallin are recognized and bound by human alphaB-crystallin chaperone.Immunoglobulin Light Chains Form an Extensive and Highly Ordered Fibril Involving the N- and C-Termini.Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction.How to manage primary amyloidosis.Convergent mechanisms favor fast amyloid formation in two lambda 6a Ig light chain mutants.Integrative Transcriptomic and microRNAomic Profiling Reveals Immune Mechanism for the Resilience to Soybean Meal Stress in Fish Gut and LiverMutational and genetic determinants of λ6 light chain amyloidogenesis
P2860
Q27022257-FFB64DFC-F616-46F7-BE48-2145E06692CDQ27661519-9C418809-F2D3-4DA3-B040-193E74B287C3Q30394403-F0C1FC53-B616-406A-9507-B1056214FF22Q33867198-BDA7ECFE-ED9E-4DEC-A855-1B98F0999D39Q34283400-550B1431-D178-4351-BE65-7A0EF2BF76BFQ36201752-3E33213B-9DE6-4BCF-971F-24BF40278103Q36466773-28B59A9D-0F2C-4A2A-AFF4-686B65349E95Q37804635-170E06EC-285E-47A4-A06D-D2AC2DBA0700Q40614534-CCEBD114-45D6-40A6-8BFB-8D143D63072DQ41106816-B7B2E33E-650C-41A7-99BC-E585F2F6CAFFQ41606174-06B6FF21-6A00-4626-B6BD-D370E3679445Q42073561-B814B22E-901D-41F6-86CD-A58D1911FC14Q42319096-D4407E8C-8D04-4FD2-BE86-115F6ED98303Q42794523-4630F5FB-F0C1-4C41-8209-A26A805B6C3EQ46400142-AFECF0C7-BA45-45AC-ABE3-81BEAE073BBFQ48137977-EC973DFE-0104-42D2-B8CE-005099A604E8Q58754083-F580A165-A650-40E6-A81C-74014F4E7F58Q58925865-17127878-E114-4F8B-A752-651326A81146
P2860
Light chain amyloidosis - current findings and future prospects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Light chain amyloidosis - current findings and future prospects.
@en
Light chain amyloidosis - current findings and future prospects.
@nl
type
label
Light chain amyloidosis - current findings and future prospects.
@en
Light chain amyloidosis - current findings and future prospects.
@nl
prefLabel
Light chain amyloidosis - current findings and future prospects.
@en
Light chain amyloidosis - current findings and future prospects.
@nl
P2093
P2860
P1476
Light chain amyloidosis - current findings and future prospects.
@en
P2093
Elizabeth M Baden
Laura A Sikkink
Marina Ramirez-Alvarado
P2860
P304
P356
10.2174/138920309789351949
P577
2009-10-01T00:00:00Z